Characteristics | Limited resection (n = 73) | Pancreaticoduodenectomy (n = 52) | P value |
---|---|---|---|
Age | Â | Â | 0.160 |
  ≤ 60 | 31 (54.4%) | 30 (68.2%) |  |
  > 60 | 26 (45.6%) | 14 (31.8%) |  |
Gender | Â | Â | 0.976 |
 Male | 27 (42.9%) | 22 (43.1%) |  |
 Female | 36 (57.1%) | 29 (56.9%) |  |
Tumor size | Â | Â | 0.035 |
  ≤ 2 cm | 12 (17.4%) | 2 (4.0%) |  |
 2–5 cm | 33 (47.8%) | 19 (38.0%) |  |
 5–10 cm | 17 (24.6%) | 20 (40.0%) |  |
  > 10 cm | 7 (10.1%) | 9 (18.0%) |  |
Mitotic index |  |  | < 0.001 |
  ≤ 5 | 50 (86.2%) | 25 (54.3%) |  |
  > 5 | 8 (13.8%) | 21 (45.7%) |  |
Morphology | Â | Â | 0.165 |
 Spindle | 35 (97.2%) | 27 (84.4%) |  |
 Epithelioid | 0 | 1 (3.1%) |  |
 Mixed | 1 (2.8%) | 4 (12.5%) |  |
NIH risk category | Â | Â | 0.001 |
 Very low | 10 (15.4%) | 1 (2.1%) |  |
 Low | 28 (43.1%) | 11 (22.9%) |  |
 Intermediate | 0 | 0 |  |
 High | 27 (41.5%) | 36 (75.0%) |  |
Neoadjuvant therapy | Â | Â | 0.401 |
 No | 69 (94.5%) | 51 (98.1%) |  |
 Yes | 4 (5.5%) | 1 (1.9%) |  |
Adjuvant therapy | Â | Â | 0.777 |
 No | 33 (80.5%) | 30 (83.3%) |  |
 Yes | 8 (19.5%) | 6 (16.7%) |  |